US medical plastics market is projected to grow from $14.8 billion in 2025 to reach $30.2 billion by 2035 and is growing at a CAGR of 7.4% during the forecast period 2026-2035. The US medical plastics market is shaped by rising demand for single-use medical products. Hospitals continue to prioritize hygiene and infection control. This supports higher consumption of disposable medical components. Material innovation is gaining attention across device manufacturing. Plastics with improved strength and biocompatibility are increasingly adopted. Regulatory compliance is influencing material selection decisions. Sustainability concerns are also guiding procurement strategies.
Browse the full report description of “US Medical Plastics Market Size, Share & Trends Analysis Report by Plastic Type (Traditional Plastics (Polyvinylchloride (PVC), Polyethylene (PE), Polystyrene (PS), Polypropylene (PP), and Silicone), Engineered Plastics (Nylon, Polycarbonate (PC), Polyoxymethylene (POM), Acrylonitrile butadiene styrene (ABS), Polymethylmethacrylate (PMMA), Polyphenylene Oxide (PPO), and Others), and by Application (Disposables, Diagnostic Instruments, Catheters and Syringes, Implants, Dental Tools, Surgical Instruments, Medical Bags, Drug Delivery Devices, and Others) Forecast Period (2026-2035)” of https://www.omrglobal.com/industry-reports/us-medical-plastics-market
Growth in outpatient care is influencing product design requirements. Compact and lightweight medical devices are gaining traction. This increases reliance on high-performance plastic materials. Automation in medical manufacturing is improving consistency and scale. Plastics support precision molding and cost efficiency. Demand from diagnostic and drug delivery applications remains steady. Long-term demand is supported by an aging population and chronic disease burden.
US Medical Plastics Market Supported by Strong Domestic Plastics Industry Scale
The scale of the US plastics industry creates a strong foundation for the medical plastics market. Large employment levels support specialized manufacturing, quality control, and regulatory compliance required for healthcare applications. High shipment values reflect advanced production capacity and reliable supply chains. This enables consistent availability of medical-grade polymers for devices, packaging, and disposables. Supplier integration further strengthens material innovation and resilience. Together, these factors support steady demand and long-term growth of medical plastics within the US healthcare ecosystem.
Key Players Shaping the Growth of the US Medical Plastics Market
The key players in the medical plastics market are Dow Inc., Celanese Corporation, Eastman Chemical Company, DuPont de Nemours, Inc., and Trinseo S.A., among others. These players focus on expanding material portfolios to meet evolving medical application needs. Emphasis remains on product quality, regulatory compliance, and consistent supply capabilities. Investments in advanced polymers support demand from devices, packaging, and diagnostic uses. Strategic collaborations and capacity enhancements continue to strengthen market presence.
Market Coverage
Key questions addressed by the report.
US Medical Plastics Market Report Segment
By Plastic Type
By Application
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/us-medical-plastics-market